In modern longevity biochemistry, stress should not be interpreted as a mere psychological condition, but as a complex shift in neuroendocrine homeostasis that affects every organ system. The human body houses sophisticated response systems to adverse stimuli, orchestrated primarily by the Hypothalamic-Pituitary-Adrenal (HPA) axis, the true conductor of our resilience to change.
Stress, in fact, is nothing other than the body’s response to change, and this change does not have to be negative. When a stressor—whether physical, biochemical, or emotional—persists beyond the subject’s recovery capacity, we enter a state perceived as chronic stress. This transition marks the beginning of a downward trajectory in which chronic, dysregulated cortisol production stops being protective and becomes toxic, triggering neuroinflammation and other endocrine effects, such as insulin resistance.
From this perspective, supplementation is not aimed at erasing stress, but at supplying the body with the substrates necessary to modulate this hormonal cascade. Compounds such as adaptogens, minerals, and neuroactive amino acids act by regulating the sensitivity of glucocorticoid receptors and stabilizing synaptic transmission in the brain. However, individual variability in managing stress load requires a deep understanding of the action mechanisms of each plant extract or bioactive molecule used. Understanding the biochemistry of the HPA axis is the essential first step to structuring supportive strategies.
The HPA Axis: The Hormonal Conductor
To understand how some supplements can modulate the stress response, it’s necessary to analyze the function of the Hypothalamic-Pituitary-Adrenal (HPA or HPI) axis, the neuroendocrine system that governs the organism’s adaptation to environmental challenges. This axis operates through a coordinated biochemical cascade: the hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the anterior pituitary to secrete adrenocorticotropic hormone (ACTH), which in turn drives the adrenal cortex to produce cortisol.
Under optimal physiological conditions, cortisol follows a strict circadian rhythm, with a peak upon awakening (the Cortisol Awakening Response, CAR) necessary to provide morning energy, followed by a gradual decline throughout the day to a low in the evening just before sleep.
By contrast, melatonin acts as the functional antagonist to cortisol, following a mirrored curve needed for rest. While cortisol drops to prepare the body for calm, melatonin should rise progressively to facilitate sleep onset and nocturnal cellular repair. A high melatonin level in the evening guarantees recovery, but if it remains low due to stress or blue light exposure, cortisol stays dangerously elevated, blocking the transition from the alert to the sleep phase and causing nighttime problems. Moreover, chronic stress disrupts this delicate balance, leading to persistent cortisol secretion that saturates glucocorticoid receptors and undermines the mechanism normally used to dampen stress signaling.
When the HPA axis’s “off switch” stops functioning properly, the body remains in a constant state of alert, a condition commonly known as chronic stress. This cortisol excess is not harmless: at the brain level, it can cause dendritic atrophy in the hippocampus, the region responsible for memory and emotional regulation, fostering mental fog and irritability, but also difficulties in remembering things.
Systemically, elevated cortisol stimulates gluconeogenesis and reduces insulin sensitivity, promoting visceral fat accumulation and low-grade chronic inflammation. Over time, chronic hyperactivation can evolve into what is popularly called “adrenal fatigue,” but scientifically it is an HPA axis dysfunction characterized by a flattening of the cortisol curve. In this condition, the hormonal battery is drained: in the morning cortisol does not rise enough to give a vital push, leaving us tired upon waking. During the day, the body attempts to compensate with adrenaline, creating a sense of constant nervous agitation, yet lacking true steady energy. Paradoxically, you end up tired but anxious, unable to concentrate yet unable to truly relax.
Regarding patient support, understanding this dynamic is crucial because it allows us to differentiate between acute stress, which calls for relaxing molecules, and dysfunctional chronic stress, which requires adaptogens capable of recalibrating receptor sensitivity. The clinical goal is not to lower cortisol at all costs, but to restore its proper activity and the HPA axis’s ability to respond to stimuli without getting stuck in a hyper-reactive, destructive state. Therefore, a well-studied approach is needed to support individuals under chronic stress through supplementation.
Supplementation with Withania somnifera
It is essential to make a fundamental caveat: dietary supplements, though of natural origin, are biologically active molecules in every sense. They can interact significantly with various classes of medications (such as sedatives, antidiabetic drugs, or thyroid hormones) and their use should never be a DIY endeavor or based on generic online tips. Any intervention on biochemistry must be preceded by consultation with a healthcare professional who can assess safety and suitability of supplementation in the individual clinical context.
Ashwagandha (Withania somnifera), also known as the “Indian ginseng,” is a shrub in the nightshade family whose root contains a unique phytochemical complex: withanolides. These compounds are responsible for classifying Ashwagandha as a “secondary adaptogen,” meaning a substance capable of increasing the body’s nonspecific resistance to physical and biological stressors. An adaptogen is a natural compound capable of increasing the body’s nonspecific resistance to physical, chemical, or biological stressors. Unlike a stimulant, it works by rebalancing systemic functions: it supports energy when we are exhausted and calms the system when we are hyperexcited, returning the body to a state of dynamic homeostasis. Unlike other supplements, Ashwagandha acts on an important mechanism of cortisol regulation, directly affecting hypothalamic receptor sensitivity.
In modern scientific literature, the effectiveness of this plant is closely linked to the use of high-concentration standardized extracts, including two important formulations: KSM-66 and Sensoril.
The KSM-66 is a broad-spectrum extract obtained exclusively from the roots, which preserves the plant’s natural balance of constituents but guarantees a withanolide concentration above 5%. Numerous double-blind clinical studies conducted with KSM-66 have shown reductions in serum cortisol levels that can reach 27–30% in individuals with chronic stress. This does not mean the plant “blocks” cortisol, but rather that it facilitates a return to baseline levels more rapidly after a stressful event, improving HPA axis resilience.
The Sensoril extract, on the other hand, uses both roots and leaves, achieving an even higher standardization of withanolides (about 10%), often proving more effective where a decisive anxiolytic action and support for nighttime rest are needed.
Beyond its hormonal effects, Ashwagandha exerts a GABAergic action, mimicking the activity of the neurotransmitter GABA (gamma-aminobutyric acid) in the central nervous system. GABA is the primary inhibitory neurotransmitter in the central nervous system: it acts as the brain’s biochemical brake. In stressful situations, neural circuits tend toward hyperexcitability due to excess glutamate (excitatory). GABA intervenes by binding to its receptors to reduce the firing frequency of neurons, promoting muscle relaxation and mental calm. Without proper GABAergic activity, the body remains locked in a state of constant alertness, making recovery difficult and profoundly altering sleep quality at night.
Here’s why this Ashwagandha activity helps reduce neural hyperexcitability typical of people living in perpetual alertness, facilitating muscle relaxation and improving sleep onset without causing morning grogginess. It’s interesting to note how Ashwagandha supplementation also supports thyroid function, promoting the conversion of T4 to T3, which explains why many patients report a boost in overall energy levels. In athletic contexts, the cortisol effect translates into better muscle recovery and a potential increase in strength, since chronically high cortisol levels are notoriously catabolic to muscle tissue.
The standard dosing protocol generally calls for amounts between 300 and 600 mg per day, preferably split into two doses to maintain steady bioavailability of the active constituents. The duration of treatment should be assessed by a professional, but maximum benefits are typically observed after 6–8 weeks of continuous use, the time needed for the neuroendocrine system to stabilize at the new parameters.
Ashwagandha is therefore not a sedative, but a system modulator that helps the individual avoid breaking under the weight of allostatic load, preserving the integrity of cognitive and metabolic functions. Choosing a high-quality, properly titrated extract is the essential condition to move from a simple herbal remedy to a true precision nutraceutical therapy.
Ashwagandha: Functional Profile
| Characteristic | Technical Detail | Clinical Benefit |
| Class | Secondary Adaptogen | Increases nonspecific resistance to stressors |
| Active Molecules | Withanolides (steroidal lactones) | Modulation of cortisol receptor signaling |
| HPA Mechanism | Reduction of CRH and ACTH | Anchors cortisol to physiological levels |
| Neurochemical Action | GABAergic agonist | Reduces anxiety and improves sleep |
| KSM-66 Extract | Roots (Full-spectrum, ~5% withanolides) | Support for chronic stress and physical performance |
| Sensoril Extract | Roots + Leaves (~10% withanolides) | Strong calming action and sleep support |
| Ideal Synergy | Magnesium and B-group vitamins | Optimization of neuromuscular relaxation |
Biochemistry and Usage Protocols
The effectiveness of Ashwagandha in modulating the HPA axis can be greatly enhanced when integrated into a synergistic protocol with specific cofactors, particularly magnesium and B vitamins. Magnesium acts as a natural partner to withanolides: while Ashwagandha works on hypothalamic reception, magnesium stabilizes the neuronal membrane and acts as an antagonist at NMDA glutamate receptors, enhancing the calming function of GABA. This combination provides robust protection against stress-induced neuronal toxicity, promoting deep muscular relaxation and reducing the physical tension often accompanying chronic anxiety.
Vitamin B complex, especially B6, B9 (folic acid), and B12, are indispensable for neurotransmitter synthesis. Without adequate intake of these vitamins, the body struggles to produce serotonin and GABA, making Ashwagandha’s mood-stabilizing effects less impactful. Moreover, Vitamin B5 (pantothenic acid) is directly involved in adrenal gland health, supporting cellular energy production and preventing the functional collapse of the HPA axis typical of nervous exhaustion. Regarding dosing, the pharmacokinetics of withanolides suggest several key rules to maximize benefits.
Although Ashwagandha does not require a fatty meal like fat-soluble supplements such as CoQ10, taking it during or right after meals improves gastrointestinal tolerability, avoiding potential mucosal irritation. Nausea and possible acid reflux are among the most common adverse effects of this extract, which is why dividing the daily dose is highly recommended. A morning dose helps modulate the cortisol response during the workday, while an evening dose leverages the GABAergic effect to improve sleep quality.
A common mistake is sporadic “as-needed” use: Ashwagandha reaches its maximum adaptogenic potential through biochemical accumulation that requires consistent dosing for at least 4–8 weeks. This is a key point to explain clearly to patients, as this supplement has a slower effect than some drugs used for stress or anxiety, generally proving effective only about a month after the first dose. Finally, it is prudent to consider 1–2 week breaks after cycles of three months to avoid receptor adaptation phenomena and maintain the endocrine system’s sensitivity to the plant’s active ingredients. In practice, continuous use often reduces the herb’s effects, rendering it less active.
In conclusion, precision supplementation with Ashwagandha represents a significant aid for rebalancing the HPA axis and managing the modern stress load. Biochemical analysis reveals that this plant does not act as a mere sedative, but as a systemic modulator capable of “recalibrating” the cortisol hormonal response, restoring the body’s natural capacity for adaptation and recovery. However, the success of this intervention rests not on the molecule alone, but on understanding its synergies with cofactors such as magnesium and B vitamins, as well as respecting the physiological timing of cellular responses. The use of standardized, titrated extracts (such as KSM-66 or Sensoril) also provides strong scientific evidence necessary to transform a traditional remedy into a modern and important clinical protocol.
Nevertheless, it’s imperative to remember that stress management cannot be separated from a holistic view of the patient: supplementation should be understood as temporary, targeted support, embedded within a lifestyle framework and proper circadian rhythm hygiene. No nutraceutical support, no matter how advanced, can fix chronic sleep deprivation. Nighttime rest is the only moment when the brain activates the glymphatic system to clear metabolic waste and reset the HPA axis. Without proper sleep hygiene, supplementation can only have a palliative effect. Deep sleep represents the only effective moment for recalibrating the brain and the nervous system.
Additionally, it is important to remember the complexity of potential interactions with preexisting pharmacotherapies, which require that every dosing protocol be validated and monitored by a competent health professional. Only through expert supervision can dosage and duration be tailored to the individual’s real needs, ensuring a safe, effective, and durable mitochondrial health-focused health journey.
From the October 2026 issue of Integrative Medicine
Bibliography
- Chandrasekhar, K et al. “A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults.” Indian Journal of Psychological Medicine vol. 34,3 (2012): 255-62.
- Gopukumar K, Thanawala S, Somepalli V, Rao TSS, Thamatam VB, Chauhan S. Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study. Evid Based Complement Alternat Med. 2021 Nov 30;2021:8254344.
- Langade D, Thakare V, Kanchi S, Kelgane S. Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients: A double-blind, randomized, parallel-group, placebo-controlled study. J Ethnopharmacol. 2021 Jan 10;264:113276.
- Abedon, B. A Standardized Withania Somnifera Extract Significantly Reduces Stress-Related Parameters in Chronically Stressed Humans: A Double-Blind, Randomized, Placebo-Controlled Study.
- Mikulska P, Malinowska M, Ignacyk M, et al. Ashwagandha (Withania somnifera)-Current Research on the Health-Promoting Activities: A Narrative Review. Pharmaceutics.
Subscribe to Integrative Medicine